Purchase Order 75N91019P00806
Award Date 9/19/19
Potential Completion Date 5/31/24
Potential Value $53K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fargo, ND 58104, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Aldevron, L.L.C., a for-profit limited liability company and manufacturer of biological products. The $7,930.00 contract is for the provision of 7 units of custom plasmid purification with endotoxin requirement, at a unit price of $1,125.00. This contract supports medical research and development efforts,...
- This federal contract award, identified as HHSN272201400873P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $7,335.00 firm-fixed-price purchase order was awarded to Aldevron, L.L.C., a for-profit limited liability company and manufacturer of biological products, to provide 15 units of AMBIS 1695546 PLASMID PREP, 3MG, CAT # 3000, at a...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $34,697.53 firm fixed price purchase order to Genscript USA Inc. to provide DNA services in support of vaccine development efforts. Under the contract, Genscript will deliver gene synthesis, VectorArk cloning, and express plasmid preparation services. These services will enable the creation of peptide and protein immunogens as well as DNA constructs containing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for "EXPRESS PLASMID PREPARATION, EXPRESS MUTAGENESIS TARGET AND CLONEARK PLASMID PREPARATION" services. The $149,984.10 contract has a completion date of September 13, 2022 and does not have a set-aside designation. Genscript has provided similar services to support...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $149,960.00 firm fixed price purchase order contract to Geneuniversal Inc., a for-profit biotechnology company, for gene synthesis, site-directed mutagenesis, PCR cloning, and plasmid preparation services. This award supports the NIH Vaccine Research Center's efforts to develop vaccines and antibodies against HIV and other viruses, by...
- <p>This is a $29,700.00 Firm Fixed Price purchase order contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Proteogenix, a for-profit manufacturer, for a phage-display VHH antibody screening service to develop in vivo gene therapy. The contract has an ultimate completion date of August 6, 2025. The contract was awarded on August 7, 2024 and does not have a set-aside designation.</p>
- This is a $10,594.44 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey, without a set-aside designation. The contract requires Genscript to provide a range of molecular biology products and services, including gene synthesis, gene...
- This firm-fixed price purchase order contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Expression Manufacturing LLC, a for-profit limited liability company, to provide 250 ml of concentrated lentiviral vector and conduct stability testing. The contract, valued at $648,968.00, has an ultimate completion date of August 31, 2029. This sole-source procurement was originally...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Promega Corporation for a custom large scale RNA transcription system. The $128,200 contract calls for Promega to deliver eight units of its AX7650X system over four shipments between July 2022 and May 2023 to support the NIH Vaccine Research Center's mRNA vaccine development efforts. The solicitation indicated the...